Table of Contents
<< Previous Issue | Jul 2023 (Vol: 2023, Issue: 7) | Next Issue >> |
- Section: Mergers & Acquisitions
-
Lilly to Acquire Diabetes Cell Therapy Partner Sigilon for US$35 M Upfront
- Section: Research & Development
-
Takeda and F-star Collaborate on Next-Generation Antibodies